Thrombopoietin mimetics are drugs that considerably increase platelet production by stimulating the receptor for the hormone thrombopoietin; Romiplostim and Eltrombopag are examples.[1] Thrombopoietin mimetics are a type of thrombopoietic agents. There has been a development of a registry of pregnant patients that were treated with these drugs.[2]

References

edit
  1. ^ "JPAC - Transfusion Guidelines".
  2. ^ Ronald Hoffman; Edward J. Benz, Jr.; Leslie E. Silberstein; Helen Heslop; Jeffrey Weitz; John Anastasi (2013). Hematology: Basic Principles and Practice. Elsevier Health Sciences. p. 2135.